๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Crohn Disease
Clinical trial register · Canada

Crohn Disease Trials in Canada, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Canada and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 6540 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:55 UTC
6540
Studies in scope
all four open statuses
3515
Recruiting now
open to new participants
887
Lead sponsors
across recruiting studies
Top sites
London 13 Vancouver 9 Toronto 9 Edmonton 7 Montreal 6
Narrow the registerReset
Recruitment status
Phase
Site location
London13 Vancouver9 Toronto9 Edmonton7 Montreal6
All 24 locations
Target enrolment
to

Crohn Disease trials in Canada

26 of 6540 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Canada
Start
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
NCT07577843Crohn Disease
Janssen Research & Development, LLC
Phase 3
460
Edmonton, Vancouver, Kentville, London, Mississauga, Toronto, Montreal
2026-05-22
Recruiting
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
NCT07483099Crohn Disease
Eli Lilly and Company
Phase 2
60
Lethbridge, London, Vaughan
2026-05-04
Recruiting
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
NCT07483073Colitis, Ulcerative, Crohn Disease
Eli Lilly and Company
Phase 2
60
Lethbridge, London, Vaughan
2026-05-04
Recruiting
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
NCT07499232Crohn Disease
Janssen Research & Development, LLC
Phase 3
530
Edmonton, Vancouver, Hamilton, London, Oshawa, Toronto, Montreal
2026-04-21
Recruiting
Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD
NCT06997965Crohn Disease
Alimentiv Inc.
Phase 4
60
Vancouver, London, Scarborough Village
2026-04-20
Recruiting
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
NCT07196722Crohn Disease
Janssen Research & Development, LLC
Phase 2/3
1,092
Edmonton, Vancouver, Kentville, Barrie, London, Oakville, Toronto, Montreal
2025-10-03
Recruiting
Lesion Size Measurement During Gastrointestinal Endoscopies
NCT07770425Polyp of Colon, Crohn Disease
Centre hospitalier de l'Universitรฉ de Montrรฉal (CHUM)
Observational
3,000
Montreal
2025-05-09
Active, closed
PRecisiOn Microbiome Directed ExtensiOn of Anti-TNFฮฑ Crohn's Disease ThErapy in Children: The PROMOTE Trial
NCT06301477Inflammatory Bowel Diseases, Crohn Disease
Children's Hospital of Eastern Ontario
Not applicable
45
Ottawa
2024-12-01
Recruiting
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
NCT06257706Moderately to Severely Active Crohn's Disease, Crohn Disease, Disease Crohn
Alimentiv Inc.
Phase 4
304
Calgary, Edmonton, Bridgewater, London, Toronto
2024-08-07
Recruiting
Predicting IBD Treatment Outcomes With Gut Microbiome Analysis
NCT06453720Inflammatory Bowel Diseases, Crohn Disease
University of British Columbia
Observational
100
Vancouver
2024-08-01
Recruiting
Bowel Preparation for Colonoscopy Among Individuals With Crohn's and Ulcerative Colitis Disease.
NCT06298461Crohn Disease, Ulcerative Colitis
University of Manitoba
Phase 4
418
Winnipeg
2024-07-04
Recruiting
Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial
NCT06216899Crohn Disease
Seattle Children's Hospital
Not applicable
60
Halifax
2024-03-11
Recruiting
Threonine Requirement in Adult Males With Crohn's Disease Using IAAO
NCT04740541Crohn Disease, IBD
The Hospital for Sick Children
Not applicable
10
Toronto
2024-02-02
Recruiting
PATHFINDER: Evaluating the Optimal First-Line Treatment Strategy for Moderate-to-Severely Active Ileal-dominant Crohn's Disease
NCT05928039Crohn Disease
University of Calgary
Phase 4
297
Calgary, Edmonton, Vancouver, Halifax, Brampton, Brantford, Hamilton, London
2023-10-25
Recruiting
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
NCT05781152Crohn Disease
Connecticut Children's Medical Center
Phase 4
900
Edmonton, London, Ottawa, Toronto
2023-06-10
Recruiting
IBD Strong Peer2Peer for Self-Management of Psychological Distress
NCT05722236Inflammatory Bowel Diseases, Ulcerative Colitis, Crohn Disease
Jennifer Jones
Not applicable
120
Halifax
2023-06-01
Recruiting
Evaluation of the SIMBA Capsule for Small Intestinal Dysbiosis
NCT05633706Irritable Bowel Syndrome, Crohn Disease, Celiac Disease, Ulcerative Colitis
Nimble Science Ltd.
Observational
300
Calgary
2023-01-09
Recruiting
Genome Analysis Across Populations in Inflammatory Bowel Disease
NCT06042387Ulcerative Colitis, Healthy, Crohn Disease, Inflammatory Bowel Diseases
Mount Sinai Hospital, Canada
Observational
150
Toronto
2022-05-01
Active, closed
Implementing a Multimodal RCT Intervention to Improve the Transition of Patients With Crohn's Disease From Pediatric to Adult Care
NCT05221281Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis, Adolescent Development
The Hospital for Sick Children
Not applicable
90
Vancouver, Ottawa, Toronto
2022-02-25
Active, closed
A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease
NCT05197049Crohn Disease
Janssen Research & Development, LLC
Phase 3
350
London, North Bay
2022-01-19
Active, closed
Proactive Infliximab Optimization Using a Pharmacokinetic Dashboard Versus Standard of Care in Patients With Inflammatory Bowel Disease: The OPTIMIZE Trial
NCT04835506Crohn Disease, Ulcerative Colitis, Inflammatory Bowel Diseases
Beth Israel Deaconess Medical Center
Phase 4
124
London, Montreal
2021-11-01
Active, closed
OptiMized REsistaNt Starch in Inflammatory Bowel Disease: The MEND Trial
NCT04520594Crohn Disease, Ulcerative Colitis, Inflammatory Bowel Diseases
Children's Hospital of Eastern Ontario
Not applicable
100
Ottawa
2021-03-03
Active, closed
Resistant Starch in Pediatric Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis)
NCT04522271Crohn Disease, Ulcerative Colitis, Inflammatory Bowel Diseases
Children's Hospital of Eastern Ontario
Not applicable
80
Ottawa
2020-08-25
Recruiting
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
NCT03816345Autoimmune Disease, Crohn Disease, Dermatomyositis, Hematopoietic and Lymphoid Cell Neoplasm
National Cancer Institute (NCI)
Phase 1
300
Toronto
2019-07-16
Active, closed
Stopping Aminosalicylate Therapy in Inactive Crohn's Disease
NCT03261206Crohn Disease, Remission
Alimentiv Inc.
Phase 4
334
Calgary, Edmonton, Vancouver, Victoria, Winnipeg, London, North Bay, Oshawa
2017-11-20
Active, closed
TDM Guided Early Optimization of ADAL in Crohn's Disease
NCT03261102Crohn Disease, Drug Monitoring, Inflammatory Bowel Diseases
waqqas.afif
Not applicable
200
Calgary, Vancouver, London, Ottawa, Montreal, Sherbrooke
2017-01-17
Rows per page Showing 1–26 of 26
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Canadian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-canada/condition/crohn-disease

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Canada and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,540 studies in total at the last sync on 26 Sep 2026, 19:55 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 26 of those studies listing the condition Crohn Disease.

How many Crohn Disease trials are recruiting in Canada?

18 of the 26 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:55 UTC sync. A further 0 have not yet opened recruitment, 8 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Crohn Disease), 26 studies
PhaseStudiesRecruitingShare
Not applicable8330.8%
Phase 47526.9%
Observational4415.4%
Phase 33211.5%
Phase 2227.7%
Phase 1113.8%
Phase 2/3113.8%

Most active sponsors

Lead sponsors with the most studies (Crohn Disease)
Lead sponsorStudiesRecruiting
Janssen Research & Development, LLC43
Alimentiv Inc.32
Children's Hospital of Eastern Ontario30
Eli Lilly and Company22
The Hospital for Sick Children21
Beth Israel Deaconess Medical Center10
Centre hospitalier de l'Universitรฉ de Montrรฉal (CHUM)11
Connecticut Children's Medical Center11
Jennifer Jones11
Mount Sinai Hospital, Canada11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.